European Thoracic Oncology Platform
c/o IBCSG | Effingerstrasse 40 | 3008 Bern | Switzerland

News

11.04.2017 | ETOP News
belief-trial-published-in-lancet-respiratory-medicineThe addition of bevacizumab to erlotinib improves progression-free survival for patients with advanced NSCLC harbouring activating EGFR and T790M mutation. Results from the BELIEF trial published in Lancet Respiratory...
29.03.2017 | ETOP News
6th-etop-residential-workshop-5-7-oct-amsterdam-application-openApplication is open for the 6th ETOP Residential Workshop taking place 5-7 October, 2017 in Amsterdam, The Netherlands.  
13.03.2017 | ETOP News
the-lancet-summit-copd-and-lung-cancerThis new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to...
25.01.2017 | ETOP News
elcc-2017-save-the-dateESMO and IASLC are pleased to announce the 7th edition of the European Lung Cancer Conference (ELCC). Register now!      

Lung Cancer Journal

ETOP members have free access to the Lung Cancer Journal

Events

05.05.2017 | Geneva, Switzerland
ELCC 2017 European Lung Cancer Conference
02.06.2017 | Chicago, USA
2017 ASCO Annual Meeting
28.07.2017 | Perth, Australia
The Lancet Summit: COPD and Lung Cancer

This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. More than 20 international speakers will lead discussion looking at shared lessons from having a better understanding of the development and management of both diseases.

Abstracts are invited by April 17, 2017 for presentation as posters to supplement the invited lectures on the following topics:

×          Prevention of COPD and lung cancer

×          Screening for COPD and lung cancer

×          Genetic insights into disease development

×          Disease management and current interventions

×          COPD and lung cancer: latest insights into treatment paradigms

×          Infectious complications in patient management

×          Latest advances in surgery and radiation

×          Post treatment and end of life care

The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in respiratory diseases and lung cancer.